Free Trial
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$36.13
-0.1%		$45.43
$15.27
▼
$52.91
$1.95B1.171.57 million shs929,753 shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$61.67
+1.7%		$72.03
$38.38
▼
$97.59
$1.81B1.06349,868 shs299,660 shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$68.90
+3.3%		$65.23
$38.91
▼
$147.03
$1.93B0.73999,823 shs867,341 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
▼
$19.01
$535.71M2.17444,551 shsN/A
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
+0.39%-9.37%-22.51%-10.84%+110.84%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-5.07%-3.85%-19.50%-31.15%+51.07%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-1.31%-5.98%+6.75%+27.81%-15.28%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+0.32%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$36.13
-0.1%		$45.43
$15.27
▼
$52.91
$1.95B1.171.57 million shs929,753 shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$61.67
+1.7%		$72.03
$38.38
▼
$97.59
$1.81B1.06349,868 shs299,660 shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$68.90
+3.3%		$65.23
$38.91
▼
$147.03
$1.93B0.73999,823 shs867,341 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
▼
$19.01
$535.71M2.17444,551 shsN/A
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
+0.39%-9.37%-22.51%-10.84%+110.84%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-5.07%-3.85%-19.50%-31.15%+51.07%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-1.31%-5.98%+6.75%+27.81%-15.28%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+0.32%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AxoGen, Inc. stock logo
AXGN
AxoGen
2.79
Moderate Buy$51.7043.09% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.78
Moderate Buy$100.2562.56% Upside
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.05
Hold$67.29-2.33% Downside
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ZIMV, INSP, AXGN, and ESTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/6/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageUnderweight$65.00
10/6/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$55.00
10/6/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
10/6/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell
10/5/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
10/1/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$60.00 ➝ $75.00
10/1/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$60.00 ➝ $53.00
10/1/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$60.00 ➝ $53.00
9/29/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold
9/25/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$48.00 ➝ $53.00
9/22/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
(Data available from 10/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AxoGen, Inc. stock logo
AXGN
AxoGen
$225.21M8.62N/AN/A$2.79 per share12.95
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$211.08M8.71N/AN/A$0.81 per share76.14
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M2.18$2.96 per share23.29$26.88 per share2.56
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.19$1.86 per share10.22$13.83 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AxoGen, Inc. stock logo
AXGN
AxoGen
-$15.70M-$0.68N/A401.44N/A-13.36%-8.90%-6.47%11/4/2026 (Estimated)
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$51.06M-$1.31N/A6,167.00N/A-15.82%-196.69%-10.73%11/4/2026 (Estimated)
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.6214.9144.455.0415.03%8.64%7.45%11/2/2026 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/AN/A-4.39%6.37%3.34%N/A

Latest ZIMV, INSP, AXGN, and ESTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
AxoGen, Inc. stock logo
AXGN
AxoGen
$0.13N/AN/AN/A$73.18 millionN/A
11/4/2026Q3 2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.2624N/AN/AN/A$66.79 millionN/A
11/2/2026Q3 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$0.0869N/AN/AN/A$204.31 millionN/A
8/6/2026Q2 2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.3368-$0.39-$0.0532-$0.39$65.79 million$67.54 million
8/3/2026Q2 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2359$0.14+$0.3759$0.01$194.72 million$200.58 million
7/29/2026Q2 2026
AxoGen, Inc. stock logo
AXGN
AxoGen
$0.1214$0.12-$0.0014-$0.03$67.10 million$69.73 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AxoGen, Inc. stock logo
AXGN
AxoGen
0.07
6.60
5.04
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
12.11
3.84
2.52
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
8.55
6.16
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
2.44%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
9.99%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
62253.76 million52.45 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,00429.80 million26.83 millionOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.91 million28.27 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.21 million26.69 millionNo Data

Recent News About These Companies

Carlsmed Appoints Richard Heppenstall As CFO; Backs Annual Revenue Outlook
September 28, 2026  |  rttnews.comhttps://www.rttnews.com/3694370/carlsmed-appoints-richard-heppenstall-as-cfo-backs-annual-revenue-outlook.aspx
ZimVie Stock Guidance | NASDAQ:ZIMV | Benzinga
July 10, 2026  |  benzinga.comhttps://www.benzinga.com/quote/ZIMV/guidance
ZimVie Announces the Launch of Azure(TM) Multi-Platform Product Solutions
July 3, 2026  |  stockhouse.comhttps://stockhouse.com/news/press-releases/2023/10/17/zimvie-announces-the-launch-of-azure-tm-xa0-multi-platform-product-solutions
ZimVie Inc.
April 8, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/zimv/research-ratings?countrycode=mx
Inogen adds med tech vet to board
April 7, 2026  |  hmenews.comH
Highridge Medical begins limited rollout of activL lumbar disc
February 27, 2026  |  massdevice.comhttps://www.massdevice.com/highridge-medical-limited-rollout-activl/
Double-digit valuations attract PE to dental care: 5 deals
January 30, 2026  |  pehub.comhttps://www.pehub.com/double-digit-valuations-attract-pe-to-dental-care-5-deals/
After years in the shadow of Big Tech, Ariel's value fund bounces back
November 14, 2025  |  chicagobusiness.comC
ZimVie Board Backs Year-End Transaction
October 27, 2025  |  msn.comhttps://www.msn.com/en-us/money/economy/zimvie-board-backs-year-end-transaction/ar-AA1PhtfW
ZimVie Inc Completes Acquisition by ARCHIMED
October 20, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/zimvie-inc-completes-acquisition-by-archimed?utm_source=marketbeat.com&utm_medium=referral
ArchiMed MedTech takes dental tech company ZimVie private for $730m
October 20, 2025  |  pehub.comhttps://www.pehub.com/archimed-medtech-takes-dental-tech-company-zimvie-private-for-730m/
ARCHIMED Completes Acquisition of ZimVie Inc. in Strategic Move to Enhance Dental Implant Solutions
October 20, 2025  |  quiverquant.comQ
ZimVie Announces Completion of its Acquisition by ARCHIMED
October 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/20/3169457/0/en/zimvie-announces-completion-of-its-acquisition-by-archimed.html
Inside 4 orthopedic medtech splinters
October 15, 2025  |  beckersspine.comB
ZimVie Shareholders Approve Acquisition, Set for October Delisting
October 12, 2025  |  aktiencheck.deA
ZimVie Inc Stockholders Approve Acquisition by ARCHIMED
October 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/zimvie-inc-stockholders-approve-acquisition-by-archimed?utm_source=marketbeat.com&utm_medium=referral
ZimVie Inc.: ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
October 10, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-10/66668515-zimvie-inc-zimvie-stockholders-vote-to-approve-acquisition-by-archimed-399.htm
ZimVie shareholders approve acquisitiion by ARCHIMED
October 10, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/zimvie-shareholders-approve-acquisitiion-by-archimed/ar-AA1OetFl
ZimVie Stockholders Approve Merger with ARCHIMED Affiliate, Closing Expected on October 20, 2025
October 10, 2025  |  quiverquant.comQ
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
October 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/10/3164889/0/en/zimvie-stockholders-vote-to-approve-acquisition-by-archimed.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Micron, Coherent and Tower Semiconductor: 3 Stocks Built on AI's Bottlenecks
NVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In It
By Bridget Bennett | September 20, 2026
Stacks of coins rising on a desk beside a computer with an upward stock chart, with a blurred city skyline behind.
3 Dividend Kings to Buy While They’re Still Beaten Down
By Thomas Hughes | September 14, 2026
Shopping bags sit on a polished marble floor inside an upscale retail store or shopping mall.
3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
By Nathan Reiff | September 16, 2026
Autonomous military drone with AV-style logo on the nose sitting on a runway, representing AeroVironment and the defense drone industry.
AeroVironment's Record Backlog and Earnings Beat Fuel Recovery Case
By Thomas Hughes | September 10, 2026
Laboratory workstation with a centrifuge, pipettes, sample racks, and automated liquid-handling equipment on a metal bench.
3 Emerging Biotech Stocks With Significant Upside Potential
By Thomas Hughes | September 30, 2026
AxoGen stock logo

AxoGen NASDAQ:AXGN

$36.13 -0.05 (-0.14%)
Closing price 04:00 PM Eastern
Extended Trading
$36.15 +0.02 (+0.06%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$61.67 +1.06 (+1.75%)
Closing price 04:00 PM Eastern
Extended Trading
$61.63 -0.04 (-0.06%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$68.90 +2.21 (+3.31%)
Closing price 03:59 PM Eastern
Extended Trading
$68.89 -0.01 (-0.01%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas